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Abstract The presence and cellular localization of insulin-like 
growth factor-I (IGF-I) mRNA in the small intestine of suckling 
and adult rats was studied. A sensitive reverse transcription (RT) 
competitive-polymerase chain reaction (PCR) revealed IGF-I 
gene expression in both age groups. Adult tissue contained 3-fold 
higher levels of IGF-I mRNA in comparison with sucklings. 
Using an in situ hybridization technique, IGF-I transcripts were 
localized mainly in enterocytes and goblet cells in the intestinal 
crypts of adult rats. By using this technique, IGF-I mRNA was 
not detected in jejunum of 12-day-old rats. 
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expression in the developing small intestine, we have estab- 
lished a very sensitive reverse transcription (RT) competitive- 
polymerase chain reaction (PCR) assay, and by using this 
technique, we have quantified intestinal levels of IGF- I  
mRNA in suckling and adult rats. 
Exact cellular localization of IGF- I  mRNA transcripts in 
the small intestine is not defined. We have recently reported 
localization of epidermal growth factor (EGF) and transform- 
ing growth factor-~x (TGF-c~) mRNA in the small intestine of 
rats using a sensitive non-radioactive in situ hybridization 
technique [25]. Based on our previous experience with this 
method, we used this technique to clarify the localization of 
IGF- I  transcripts in the small intestine of suckling and adult 
rats. 
1. Introduction 
Mucosa of the gastrointestinal (GI) tract exhibits one of the 
most rapid cell turnover ates of any tissue in the body. Rap- 
idly proliferating enterocytes migrate from crypt to villus tip, 
losing proliferative capacity and increasing differentiation cap- 
ability [1]. The mechanisms regulating astrointestinal growth 
are complex and are influenced by nutritional, hormonal, 
pharmacological, and luminal factors [2]. A growing body 
of evidence suggests that peptide growth factors are essential 
in the regulation of gastrointestinal growth and function. 
Insulin-like growth factor-I ( IGF-I) is a peptide that in- 
duces cell division and differentiation i a wide range of tissue 
and cell types [3-6]. A major site for the synthesis of circulat- 
ing IGF- I  is the liver, but IGF- I  peptide is also produced 
locally in a number of tissues. Therefore, IGF- I  likely has 
both paracrine and autocrine functions. Most actions of 
IGF- I  are thought to be mediated by binding to two IGF  
receptor types, called type 1 and type 2 receptors [7]. These 
receptors are distributed throughout he GI tract of several 
mammalian species, including the rat [8-16]. 
The expression of IGF- I  mRNA in rat small intestine was 
first detected by Lund et al. [17] and was later reported in 
mammalian gastrointestinal tissues of numerous other species 
[9,18-24]. Nevertheless, intestinal levels of IGF- I  mRNA dur- 
ing the suckling period, when IGF- I  peptide is delivered via 
milk, are not well described. In order to evaluate IGF- I  gene 
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2. Materials and methods 
2.1. Tissue preparation 
Sprague-Dawley male rats bred in our colony were used in this 
experiment. Adult rats were fed a standard laboratory diet (Lab 
Blox, Tech-Lab, Indianapolis, IN). Fifteen adult 65- to 75-day-old 
male rats (450-520 g) and thirty suckling 12-day-old male and female 
rats (31 35 g), originally from six different litters, were used in this 
study. Rats were anesthetized and killed by decapitation. Jejunum was 
quickly removed and snap-frozen in liquid nitrogen and stored at 
-75°C until processed for RNA extraction. Small parts of tissues 
were oriented for sectioning by embedding in OCT compound (Tissue 
Tek II, Miles, Elkhart, IN), frozen in isopentane (cooled in liquid 
nitrogen) and stored at -75°C for in situ hybridization. 
2.2. RNA extraction 
Total RNA was isolated from rat tissues using a modification of the 
single-step RNA isolation method [26]. Briefly, 1 ml of TRIzol Re- 
agent (Gibco BRL, Gaithersburg, MD) was homogenized with about 
100 mg of frozen tissue. Total RNA was recovered from the aqueous 
phase by precipitation with isopropyl alcohol, the concentration was 
calculated from the absorbance at 260 nm (A260) and the purity was 
determined by A260/A2s0 ratio (Spectronic 1000, Milton Roy Com- 
pany, Rochester, NY). The integrity of RNA samples was verified 
by electrophoresis on 1.2% agarose gels (SeaKem GTG Agarose, 
FMC BioProducts, Rockland, ME) containing formaldehyde (2.2 
M) and ethidium bromide in 1 x MOPS [40 mM MOPS (pH 7.0), 
10 mM sodium acetate and 1 mM EDTA (pH 8.0)]. 
2.3. Synthesis of IGF-I competitor DNA 
A 314 base pair (bp) long fragment of DNA containing rat IGF-I 
primer sequences was constructed using the PCR MIMIC Construc- 
tion Kit (Clontech, Palo Alto, CA). In order to be able to separate 
and quantify PCR products from competitive PCR on agarose gel, the 
size of competitor (standard) DNA was designed 167 bp shorter than 
the size of PCR product amplified from rat IGF-I mRNA. The com- 
petitive DNA was prepared in a two-step PCR reaction according to 
the standard manufacturer's protocol (Clontech). The competitor 
DNA was purified on a CHROMA SPIN column (Clontech), quanti- 
fied by spectrophotometry, and stored in aliquots at --75°C. 
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2.4. Reverse transcription (RT) 
Single-stranded complementary DNA (cDNA) was reverse-tran- 
scribed from 750 ng of total RNA in a 10 ~tl reaction mixture contain- 
ing 25 U of murine leukemia virus reverse transcriptase, 2.5 ~tM ran- 
dom hexamers, 10 U of RNase inhibitor, 1 mM of each dNTP, 5 mM 
MgC12, 50 mM KCI and 10 mM Tris-HC1 (pH 8.3). All chemicals 
used were from Perkin Elmer, Norwalk, CT. The reaction mixture 
was incubated for 20 min at room temperature, 25 min at 42°C, 
and then the enzyme was heat inactivated for 5 min at 99°C. The 
reaction mixture was kept at 4°C until the start of PCR amplification. 
The amounts of total RNA used in the RT reactions were calculated 
from the absorbance at 260 nm, and verified by densitometry of the 
28S ribosomal RNA band separated on denaturating a arose gels (by 
Gel Doc 1000 Documentation System with Molecular Analyst/PC 
software, BIO-RAD, Hercules, CA). 
2.5. Competitive PCR amplification 
The reverse transcriptase product (10 Ixl) was mixed with a 40 ~tl 
PCR reaction mixture containing 0.2 I.tM of each of the upstream and 
downstream rat IGF-I primer, 1 U of Taq DNA polymerase (Perkin 
Elmer), 1 mM MgC12, 50 mM KC1 and 10 mM Tris-HC1 (pH 8.3). 
Two ~tl of a defined concentration of competitor DNA was added to 
each tube. Rat IGF-I primers were synthesized by Biosource Interna- 
tional, Menlo Park, CA. The IGF-I sense primer was 5'- 
ACATCTCCCATCTCTCTGGA-3' (nucleotides 99-118); the IGF-I 
antisense primer was 5'-TCTGAGTCTTGGGCATGTCA-3' (nucleo- 
tides 561-580) [27]. The mixture was subjected to 30-35 cycles of PCR 
amplification on a Perkin Elmer DNA Thermal Cycler 480. The PCR 
cycle conditions included: melting for 1 min at 94°C, annealing for 
1 min at 63°C and primer extension for 2 min at 72°C. 
Twenty til of the amplification products were separated on 2% 
agarose gel in 40 mM Tris-acetate, 1 mM EDTA (pH 8.0) buffer, 
stained with ethidium bromide. The band densities were evaluated 
by using Gel Doc 1000 system with Molecular Analyst/PC software 
(BIO-RAD). In order to assess relative amounts of natural IGF-I 
PCR product, the density ratios between the competitor and the tar- 
get bands were calculated. The PCR products were size-verified using 
a DNA ladder and the identity of natural IGF-I PCR band was 
confirmed by Southern blot analysis using a digoxigenin-labeled 
(DIG-labeled) antisense IGF-I RNA probe. Control reactions without 
reverse transcriptase or without otal RNA yielded no product bands. 
2.6. In situ hybridization and probes 
In situ hybridization was performed using a technique previously 
described in detail [25]. A 786 bp EcoRI fragment of rat IGF-I 
cDNA, P2 [27], cloned into plasmid pGEM 4Z (Promega, Madison, 
WI) was kindly provided by Dr. P.K. Lund, University of North 
Carolina, Chapel Hill, NC. Antisense and sense RNA probes were 
generated by in vitro transcription using the RNA Labeling Kit 
(Boehringer Mannheim, Indianapolis, IN) according to the standard 
manufacturer's protocol. Size of the RNA probes was verified by 
electrophoresis. DIG incorporation was measured by dot blot analysis 
of serial dilutions of the probes. Cryostat sections of rat jejunum (6-8 
I-tm) were treated with proteinase K at 37°C for 10 min, then prehy- 
bridized with hybridization buffer (HB) at 37°C for 2 h. Hybridization 
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Fig. 1. IGF-I mRNA intestinal levels quantified by RT competitive- 
PCR. Total RNA extracted from jejunum of adult and suckling rats 
was reverse-transcribed into cDNA. A constant amount of intestinal 
cDNA was co-amplified with two-fold serial dilutions of the compe- 
titor DNA. The natural 481- and competitor (standard) 314-bp-long 
PCR products after amplification for 30 cycles were subjected to 
electrophoresis on 2% agarose gel stained with ethidium bromide. 
The following amounts of the competitor DNA were used: lanes A, 
12.8x10 -2 amol; lanes B, 6.4x10 -2 amol; lanes C, 3.2×10 -2 
amol. 
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Fig. 2. Quantification of IGF-I mRNA by using RT competitive- 
PCR. Competition between atural IGF-I PCR product and compe- 
titor PCR product (used in four different concentrations) was deter- 
mined by computer imaging the intensity of 481 and 314 bands on 
agarose gel. Mean values of the logarithm of the density ratio of 
natural (target) to competitor (after correction for the difference in 
size) were plotted as a function of the logarithm of the amount of 
competitor added to the reaction. The total amounts of IGF-I 
mRNA in the samples were calculated from the competitor values 
at the equivalence points (log density ratio = 0). 
buffer contained: 50% formamide, 0.75 M NaC1, 25 mM EDTA, 1 x 
Denhardt's, 0.1 M dithiothreitol (DTT), 0.2% sodium dodecyl sulfate 
(SDS), 100 p.g/ml yeast transfer RNA, and 300 ~tg/ml heat denatured 
herring sperm DNA. After prehybridization, 20 ~tl of HB (without 
herring sperm DNA) containing DIG-labeled antisense or sense (for 
control sections) RNA probes were added to each section, and the 
slides were incubated in a moist chamber at 55°C overnight. The 
signal was detected by using the Nucleic Acid Detection Kit (Boeh- 
ringer Mannheim) according to the standard manufacturer's protocol. 
The sections were lightly counterstained with hematoxylin and stored 
in the dark. 
3. Results 
3.1. Quantification o f  IGF-I  mRNA 
The sensitive RT  competit ive-PCR was used for quantifica- 
t ion of IGF- I  mRNA levels in the small intestine. Fig. 1 
shows a typical picture resulting from RT competit ive-PCR 
used for the quantif ication of IGF- I  mRNA in the je junum of 
adult and suckling rats. To correct for differences in nucleo- 
tide length, the band density of the competitor was multiplied 
by 1.5 (i.e. 481/314). The logarithm of the density ratio of the 
target band to the competitor band was then plotted versus 
the logarithm of the starting concentrat ion of competitor 
DNA (Fig. 2). At  the competit ion equivalence point (log den- 
sity ratio = 0), the original concentrat ion of IGF- I  cDNA in 
the PCR reaction corresponds to the initial concentrat ion of 
competitor  DNA.  The values obtained for the equivalence 
point were multiplied by a factor of 2, because the competitor 
DNA was double-stranded and the target cDNA was single- 
stranded at the beginning of the PCR reaction. 
The total amounts of IGF- I  mRNA (mean + S.E.M.) calcu- 
lated in rat je junum were 0.141 + 0.013 and 0.049 + 0.004 amol 
of IGF- I  mRNA per/.tg of  total RNA in adults (n = 10) and 
in 12-day-old sucklings (n = 12), respectively. However, it is 
necessary to assume that the reverse transcription of mRNA 
into cDNA is performed with high efficiency. Since all samples 
were assayed under the same reaction conditions, we consider 
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Fig. 3. In situ hybridization of IGF-I mRNA with DIG-labeled RNA probes in sections of adult male rat jejunum. A strong positive signal for 
the presence of IGF-I mRNA is noted in the crypt cells (A). Hybridization with control IGF-I sense-RNA probe (B). Original magnification 
x 200. 
it more appropriate to present our results as a relative differ- 
ence between adult and suckling intestinal tissues. In sum- 
mary, the expression of IGF-I mRNA in rat jejunum was 
about 3-fold higher in adults than in sucklings. 
3.2. Localization o f  IGF- I  mRNA 
To determine the histological localization of IGF-I mRNA 
in the rat GI tract, in situ hybridization was performed. 
In duodenum and jejunum of adult male rats, an intense 
positive staining was evident in the intestinal crypt cells (Fig. 
3A). The enterocytes of the lower half of the villus either 
exhibited faint, or in most cases, no staining for the presence 
of IGF-I mRNA. No staining was observed in the upper half 
of the villus. After hybridization with the sense IGF-I probe, 
no signal was detected (Fig. 3B). Greater magnification of 
intestinal crypts suggested localization of IGF-I mRNA 
mainly to the enterocytes from the upper part of the crypt 
and in the goblet cells (Fig. 4). One out of four animals ex- 
hibited a very light 'positive' staining in a few lamina propria 
cells. However, the same intensity of staining was also ob- 
served in serial sections after hybridization with the sense 
control probe. 
In suckling male rats (12 days old), no positive staining for 
the presence of IGF-I mRNA was detected either in the crypt 
cells or in the lamina propria after hybridization with the 
antisense probe (results not shown). 
4. Discussion 
Although the presence of IGF-I mRNA in rat intestinal 
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Fig. 4. Detail of the section from rat jejunum. A strong positive signal is detected in the enterocytes from the upper part of the crypts and in 
the goblet cells. Original magnification x 450. 
tissue has been previously reported, there is no detailed infor- 
mation regarding the IGF-I mRNA levels and the cellular site 
of IGF-I gene expression i  developing rat small intestine. In 
this study, we have used a very sensitive RT competitive-PCR 
to measure the IGF-I mRNA levels in the rat small intestine. 
The relative abundance of IGF-I mRNA was approximately 
3 times higher in adult rats, in comparison with suckling rats. 
An in situ hybridization technique with non-radioactive DIG- 
labeled RNA probes was used for the cellular localization of 
IGF-I transcripts in the rat small intestine. IGF-I mRNA was 
clearly detected in the crypt cells of adult male rats. A signal 
for the presence of IGF-I mRNA was also apparent in the 
enterocytes from the lower part of the villus. In contrast o 
adults, IGF-I transcripts were not detected in the small intes- 
tine of suckling rats. 
The biological functions of IGF-I within the small intestine 
are not completely known. However, a number of studies 
support he speculation that proliferative growth in the crypt 
epithelium can be stimulated by IGF-I. The expression of 
IGF-I mRNA in the G! tract has been studied mainly in 
rats. Lund et al. [17] detected IGF-I mRNA in fetal and adult 
rat intestine by using Northern blot analysis, and these find- 
ings first suggested the rat intestine as a site of IGF-I syn- 
thesis. The expression of IGF-I mRNA in the rat stomach 
during development (from late fetal to 50-days postnatal) 
was studied by using solution hybridization/RNase protection 
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assays [18]. Stomach IGF-I gene expression dramatically de- 
clined during the first postnatal week. Albiston et al. [20] 
compared the abundance of IGF-I mRNA throughout the 
adult rat GI tract. Stomach and colon exhibited significantly 
higher IGF-I expression, in comparison with the small intes- 
tine. Recently, Winesett et al. [23] presented a detailed study 
concerning the regulation of IGF-I system in the rat small 
intestine during altered nutritional status. The changes in je- 
junal mass in this study (during fasting and after refeeding) 
correlate with changes in levels of serum IGF-I and jejunal 
IGF-I mRNA. Fasting significantly reduced the abundance of
IGF-I mRNA in the jejunum. The authors suggest hat cir- 
culating and locally expressed IGF-I contribute to changes in 
jejunal mass induced by fasting and refeeding. 
Large amounts of biologically active peptides are present in 
mammalian milk, including IGF-I [28-30], and play impor- 
tant roles during development. Rat milk [31,32] contains ig- 
nificant quantities of IGF-I peptide (16.0 + 6.9 ng/ml) and it is 
likely that the GI tract is a target tissue for IGF-peptide 
[33,34]. A recent study from our laboratory showed that 
radiolabeled IGF-I and -II delivered orogastrically with milk 
to the newborn rat were recovered from the gastrointestinal 
lumen and tissue [35]. 
Previously, we have shown differences in the gene expres- 
sion and peptide levels of EGF and TGF-tx in the developing 
rat small intestine [25,36]. Based on these observations, we 
decided to quantify and localize IGF-I mRNA in the devel- 
oping small intestine. IGF-I transcripts were not detected in 
adult or suckling intestinal samples by the Northern blot tech- 
nique, probably because of the low sensitivity of this method. 
A very sensitive RT-PCR detected IGF-I gene expression in 
intestinal samples from both age groups, but was unable to 
distinguish the quantitative differences between suckling and 
adult rats (results not shown). Reverse transcription competi- 
tive-PCR was established in order to measure small differ- 
ences in the relative amounts of IGF-I mRNA with reason- 
able accuracy and reproducibility. As little as a 2-fold change 
was discernible, making the method quantitatively compar- 
able to Northern blot or RNase protection assay, and having 
the sensitivity and speed possible only with PCR. Results 
from RT competitive-PCR revealed about 3-fold higher levels 
of IGF-I mRNA transcripts in the rat small intestine of adults 
than in sucklings. 
Cellular localization of IGF-I peptide and mRNA in the 
human fetal GI tract was described by Han et al. [24,37]. 
Interestingly, IGF-I immunoreactivity was only observed in 
the epithelial cells of the mucosa with a higher intensity of 
staining in the villus than in the crypt cells. In contrast, in situ 
hybridization localized IGF-I transcripts to lamina propria 
and submucosa. Winesett et al. [23] observed a low signal 
for IGF-I expression in the cells of the lamina propria not 
only after hybridization with antisense probe, but also with 
sense (control) probe. The authors speculate that their diffi- 
culties in IGF-I localization were due to the low abundance 
and/or widespread, low-level expression of IGF-I mRNA in 
multiple cell types. 
In our study, we localized the expression of IGF-I mRNA 
to the crypt cells of adult rat duodenum and jejunum. A 
strong signal in the crypt enterocytes and goblet cells was 
elucidated upon higher magnification. The presence of IGF- 
I receptors preferentially in crypt cells [8,12], together with 
our results from in situ hybridization, suggest an autocrine/ 
paracrine role for IGF-I in the rat small intestine. Moreover, 
the decrease in detection of IGF-I transcripts from the crypt 
to the villus tip corresponds with the decreasing density of 
IGF-I receptors in the same area. These results invite specula- 
tion that IGF-I participates more in the proliferation of crypt 
cells than in the differentiation of mucosal cells, migrating 
from crypt to villus tip. Steeb et al. [38] and Zhang et al. 
[22] recently published studies demonstrating that the en- 
hancement of intestinal mucosal crypt depth, villus height, 
and villus surface area by IGF-I treatment is associated 
with a significant increase in epithelial cell proliferation. 
We were unable to localize IGF-I mRNA in the developing 
small intestine using the in situ hybridization technique. Since 
RT competitive-PCR revealed significant differences in the 
abundance of IGF-I mRNA in suckling and adult rats, we 
speculate that intestinal IGF-I mRNA levels in suckling rats 
were probably under the detectability level of the in situ hy- 
bridization technique. It seems reasonable to infer that exo- 
genous IGF-I peptide as is present in milk and bile [39], may 
down-regulate IGF-I mRNA expression i  the developing rat 
GI tract. 
These findings support studies suggesting autocrine/para- 
crine functions of IGF-I in the GI tract, as well as providing 
a rationale for further investigation of the role and fate of 
milk-borne IGF-I during intestinal development. The limita- 
tion of endogenous GI tract IGF-I synthesis observed in suck- 
ling rats may relate to significant enteral IGF-I intake via milk 
and bile. 
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